Back to GG GILDER GAGNON HOWE & CO LLC
EIDXShowing 0 of 6 quarters
Position history for GGGILDER GAGNON HOWE & CO LLC's holdings in EIDOS THERAPEUTICS INC
As of its Q4 2020 13F, Gilder Gagnon Howe held 333,176 shares of EIDX (Eidos Therapeutics), worth $43.8M. Gilder Gagnon Howe's 13F filings listed EIDX from Q4 2019 to Q4 2020, 5 quarterly filings. EIDX was 0.2% of Gilder Gagnon Howe's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of EIDX: RA CAPITAL MANAGEMENT, L.P.